Northern Trust’s Evolus EOLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Buy |
472,343
+27,177
| +6% | +$132K | ﹤0.01% | 2992 |
|
|
2025
Q4 | $2.96M | Sell |
445,166
-107,244
| -19% | -$727K | ﹤0.01% | 2768 |
|
|
2025
Q3 | $3.39M | Buy |
552,410
+52,940
| +11% | +$413K | ﹤0.01% | 2723 |
|
|
2025
Q2 | $4.6M | Sell |
499,470
-28,643
| -5% | -$293K | ﹤0.01% | 2503 |
|
|
2025
Q1 | $6.35M | Sell |
528,113
-3,054
| -0.6% | -$39.9K | ﹤0.01% | 2292 |
|
|
2024
Q4 | $5.86M | Buy |
531,167
+45,384
| +9% | +$638K | ﹤0.01% | 2413 |
|
|
2024
Q3 | $7.87M | Buy |
485,783
+103,360
| +27% | +$1.44M | ﹤0.01% | 2204 |
|
|
2024
Q2 | $4.15M | Sell |
382,423
-1,198
| -0.3% | -$14.7K | ﹤0.01% | 2501 |
|
|
2024
Q1 | $5.37M | Sell |
383,621
-6,995
| -2% | -$90.9K | ﹤0.01% | 2402 |
|
|
2023
Q4 | $4.11M | Buy |
390,616
+3,873
| +1% | +$34.6K | ﹤0.01% | 2614 |
|
|
2023
Q3 | $3.53M | Buy |
386,743
+15,439
| +4% | +$138K | ﹤0.01% | 2641 |
|
|
2023
Q2 | $2.7M | Buy |
371,304
+44,432
| +14% | +$383K | ﹤0.01% | 2831 |
|
|
2023
Q1 | $2.77M | Buy |
326,872
+11,345
| +4% | +$103K | ﹤0.01% | 2802 |
|
|
2022
Q4 | $2.37M | Buy |
315,527
+4,224
| +1% | +$32.7K | ﹤0.01% | 2910 |
|
|
2022
Q3 | $2.51M | Sell |
311,303
-4,927
| -2% | -$52.2K | ﹤0.01% | 2893 |
|
|
2022
Q2 | $3.67M | Buy |
316,230
+24,364
| +8% | +$287K | ﹤0.01% | 2702 |
|
|
2022
Q1 | $3.27M | Sell |
291,866
-18,067
| -6% | -$154K | ﹤0.01% | 2835 |
|
|
2021
Q4 | $2.02M | Buy |
309,933
+1,643
| +0.5% | +$11.3K | ﹤0.01% | 3221 |
|
|
2021
Q3 | $2.35M | Sell |
308,290
-34,483
| -10% | -$357K | ﹤0.01% | 3202 |
|
|
2021
Q2 | $4.34M | Buy |
342,773
+85,911
| +33% | +$945K | ﹤0.01% | 2931 |
|
|
2021
Q1 | $3.34M | Sell |
256,862
-16,285
| -6% | -$150K | ﹤0.01% | 2992 |
|
|
2020
Q4 | $918K | Sell |
273,147
-24,290
| -8% | -$91.2K | ﹤0.01% | 3542 |
|
|
2020
Q3 | $1.16M | Buy |
297,437
+81,829
| +38% | +$299K | ﹤0.01% | 3325 |
|
|
2020
Q2 | $1.14M | Sell |
215,608
-79,040
| -27% | -$364K | ﹤0.01% | 3308 |
|
|
2020
Q1 | $1.22M | Buy |
294,648
+23,718
| +9% | +$201K | ﹤0.01% | 3124 |
|
|
2019
Q4 | $3.3M | Buy |
270,930
+40,286
| +17% | +$568K | ﹤0.01% | 2832 |
|
|
2019
Q3 | $3.6M | Buy |
230,644
+66,070
| +40% | +$1.08M | ﹤0.01% | 2739 |
|
|
2019
Q2 | $2.41M | Buy |
164,574
+6,575
| +4% | +$130K | ﹤0.01% | 2977 |
|
|
2019
Q1 | $3.57M | Buy |
157,999
+2,705
| +2% | +$58.5K | ﹤0.01% | 2746 |
|
|
2018
Q4 | $1.85M | Buy |
155,294
+69
| +0% | +$984 | ﹤0.01% | 3099 |
|
|
2018
Q3 | $2.89M | Buy |
155,225
+58,729
| +61% | +$1.27M | ﹤0.01% | 3002 |
|
|
2018
Q2 | $2.7M | Buy |
96,496
+39,373
| +69% | +$695K | ﹤0.01% | 3051 |
|
|
2018
Q1 | $516K | Buy |
+57,123
| New | +$654K | ﹤0.01% | 3560 |
|
Other funds holding EOLS
NCM
B
FLSM
VCM
SCM
SCM
AC
Northern Trust's EOLS Position: Q1 2026 in Review
Northern Trust increased its Evolus (EOLS) stake by 6.1% in Q1 2026, buying an estimated $132K and bringing the position to 472,343 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2992.
Northern Trust first reported a position in EOLS in Q1 2018 and has held it in 33 quarters since. The position peaked at $7.87M in Q3 2024. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.
- Northern Trust held 472,343 shares of Evolus worth $1.94M as of Q1 2026.
- Northern Trust bought 27,177 Evolus shares in Q1 2026, an estimated $132K.
- Evolus made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2992 holding.
- Northern Trust first reported a position in Evolus in Q1 2018 and has held it in 33 quarters since.
- Northern Trust's Evolus position peaked at $7.87M in Q3 2024.
- 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.